title: [Keratomycosis - Therapy Standards and New Developments].
abstract: Mycotic keratitis is a comparatively rare but serious ophthalmological disease, that can possibly lead to a severe loss of vision up to blindness. Over the last two decades an increase of cases with mycotic keratitis has been noticed, which is possibly caused by an increased use of soft contact lenses. This article gives an overview of the typical clinical signs and symptoms of keratomycosis, tried and tested diagnostics and therapy as well as new diagnostic and therapeutic developments and findings.
authors.affiliation: Universitätsaugenklinik, Otto-von-Guericke-Universität Magdeburg.
authors.forename: W
authors.initials: W
authors.lastname: Behrens-Baumann
authors.affiliation: Augenklinik, Heinrich-Heine-Universität Düsseldorf.
authors.forename: D
authors.initials: D
authors.lastname: Finis
authors.affiliation: Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Heinrich-Heine-Universität Düsseldorf.
authors.forename: C
authors.initials: C
authors.lastname: MacKenzie
authors.affiliation: Augenklinik, Heinrich-Heine-Universität Düsseldorf.
authors.forename: M
authors.initials: M
authors.lastname: Roth
authors.affiliation: Augenklinik, Heinrich-Heine-Universität Düsseldorf.
authors.forename: G
authors.initials: G
authors.lastname: Geerling
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D003263:Contact Lenses, Hydrophilic / Q000009:adverse effects* / Q000382:microbiology; D019317:Evidence-Based Medicine; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007634:Keratitis / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents